AnaptysBio Inc’s filing revealed that its Director EcoR1 Capital, LLC acquired Company’s shares for reported $0.84 million on Dec 30 ’24. In the deal valued at $12.92 per share,65,184 shares were bought. As a result of this transaction, EcoR1 Capital, LLC now holds 7,860,180 shares worth roughly $114.6 million.
Then, EcoR1 Capital, LLC bought 13,268 shares, generating $171,513 in total proceeds. Upon buying the shares at $12.93, the Director now owns 7,873,448 shares.
Before that, EcoR1 Capital, LLC bought 6,646 shares. AnaptysBio Inc shares valued at $86,070 were divested by the Director at a price of $12.95 per share. As a result of the transaction, EcoR1 Capital, LLC now holds 7,880,094 shares, worth roughly $114.89 million.
Wolfe Research initiated its AnaptysBio Inc [ANAB] rating to an Outperform in a research note published on February 04, 2025; the price target was $25. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who decreased its forecast for the stock in mid December from “a Buy” to “a Neutral”. BTIG Research also remained covering ANAB and has decreased its forecast on December 02, 2024 with a “Neutral” recommendation from previously “Buy” rating. H.C. Wainwright started covering the stock on July 22, 2024. It rated ANAB as “a Buy”.
Price Performance Review of ANAB
On Friday, AnaptysBio Inc [NASDAQ:ANAB] saw its stock fall -9.33% to $14.58. Over the last five days, the stock has lost -18.68%. AnaptysBio Inc shares have risen nearly 10.12% since the year began. Nevertheless, the stocks have fallen -39.30% over the past one year. While a 52-week high of $41.31 was reached on 01/28/25, a 52-week low of $12.51 was recorded on 01/02/25. SMA at 50 days reached $17.33, while 200 days put it at $26.30.
Levels Of Support And Resistance For ANAB Stock
The 24-hour chart illustrates a support level at 13.86, which if violated will result in even more drops to 13.15. On the upside, there is a resistance level at 15.75. A further resistance level may holdings at 16.93. The Relative Strength Index (RSI) on the 14-day chart is 38.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.53%. Stochastics %K at 24.63% indicates the stock is a holding.
How much short interest is there in AnaptysBio Inc?
A steep rise in short interest was recorded in AnaptysBio Inc stocks on 2025-01-15, dropping by -0.39 million shares to a total of 6.6 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 6.99 million shares. There was a decline of -5.9%, which implies that there is a negative sentiment for the stock.
